Tags: Drug.

Omalizumab (trade name Xolair Roche/Genentech and Novartis) is a humanized antibody originally designed to reduce sensitivity to inhaled or ingested allergens especially in the control of moderate to severe allergic asthma which does not respond to high doses of corticosteroids. It has been approved for treating adult and adolescent patients 12 years and older with severe or moderate to severe allergic asthma in more than 90 countries since its first of such approval in 2002 in Australia.

Loading...

This page contains content from the copyrighted Wikipedia article "Omalizumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.